AmeriSourceBergen Has Resumed Distributing 340B-Priced Bausch Health Drugs

340B pricing on Bausch Health products is being restored to AmeriSourceBergen's ordering platforms, 340B Report has learned. | Source: Shutterstock

Drug manufacturer Bausch Health and distributor AmeriSourceBergen Corp. (ABC) apparently have settled their differences and 340B pricing on Bausch Health products is being restored to ABC’s ordering platforms, 340B Report has learned.

Bausch Health blindsided 340B covered entities on

Read More »

Half of Health Care Execs Surveyed Expect Biden to Act on Pharma’s 340B Pricing Denials

Half of health care industry executives surveyed last month think President Biden will take action against drug manufacturers that have stopped offering 340B pricing on their products. | Source: Advis

Half (50 percent) of a sample of health care industry C-suite executives surveyed last month expect the Biden administration to “formally obligate drug manufacturers to offer 340B pricing,” consulting firm Advis reports in its first health care industry leadership survey

Read More »

USA Today Fact-Checks Claim that Biden Raised Insulin Prices by Freezing 340B Rule

USA Today says says claims circulating on social media that the Biden administration raised insulin prices by freezing a 340B-related Trump administration rule are “missing context.”

USA Today, America’s top newspaper ranked by circulation, says claims circulating on social media that the Biden administration raised insulin prices by freezing a 340B-related Trump administration rule are “missing context.”

Last Friday, the national newspaper’s Fact Check feature

Read More »

44 New York State Lawmakers Urge Cuomo to Reverse Medicaid Drug Benefit Transfer

Forty-four New York state legislators have signed a letter to Gov. Andrew Cuomo (D) expressing “strong opposition” to the scheduled transfer in April of Medicaid managed care pharmacy benefits to Medicaid fee for service. They said the transfer “will have

Read More »

TV Humorist Bestows “Baldy” Award on Co-Author of 340B Law

Humorist Bill Maher says making "real progress" in Congress comes from "dull patient plodders" like Henry Waxman, the inspiration for and first recipient of Maher's new Baldy Award. | Source: YouTube

Humorist Bill Maher, host of HBO’s long-running Real Time with Bill Maher program, on Friday “honored” former U.S. House Energy and Commerce Chair Henry Waxman (D-Calif.) with a new award for unheralded public service—the Baldy. Waxman was a driving force

Read More »

340B Guidance Documents Removed from HHS Public Database

It is not known when the majority of the 340B guidance documents disappeared from the HHS Guidance Portal, who took them down, or why.

Nearly all 340B-related program guidance documents have been taken down from an online database that the Trump administration launched last summer to underscore its position that federal government guidance documents are non-binding.

The U.S. Health Resources and Services Administration’s (HRSA)

Read More »

340B Report Publisher/CEO: It Will Take Time for Contract Pharmacy Battle to Play Out

Recent developments in federal court bode well for 340B providers trying to restore access to 340B pricing in the contract pharmacy setting, 340B Report Publisher and CEO Ted Slafsky’s take in his latest column for the Omnicell blog

The battle in the courts among providers, drug manufacturers, and health officials over 340B contract pharmacy likely will take time to play out, 340B Report Publisher and CEO Ted Slafsky writes in his latest column for Omnicell (a 340B Report

Read More »

AHA Asks CMS to Withdraw Trump’s Most Favored Nation Drug Pricing Rule

During an October 2018 event at HHS, former President Trump promised to end "global freeloading" that caused Americans to pay higher drug prices. | Source: C-SPAN

The American Hospital Association (AHA) asked the Biden administration this week to immediately withdraw the Trump administration’s “most favored nation” (MFN) drug pricing interim final rule, in part, because of the damage it will do to 340B hospitals and “critical

Read More »

Generic Liquid Drug Manufacturer Providing Refunds for 340B Overcharges

The U.S. Health Resources and Services Administration (HRSA) is requiring Pharmaceutical Associates, Inc. (PAI), a South Carolina-based generic liquid drug manufacturer, to repay 340B covered entities for charges on its products above the 340B ceiling price discovered during a fiscal

Read More »

Drug Company Eton Posts 340B Limited Distribution Notice

Illinois-based Eton Pharmaceuticals is making its Alkindi Sprinkle hydrocortisone product available through a sole specialty distributor “to ensure that patients…receive appropriate drug and clinical counseling and to support therapeutic adherence,” the company informed 340B covered entities in a Jan. 12

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live